Home › Products › Oncology › Palbosure 125mg Capsule
Palbosure 125mg Capsule
Salt Composition: PALBOCICLIB
- Manufacturer: AXIOMMAX ONCOLOGY PVT LTD
- Pack Size: 21 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 125MG
- Prescription Required
- Storage: Keep Palbosure 125mg Capsule out of sight and reach of children. Store the Palbosure 125mg Capsule at 20°C to 25°C. Store in the original packaging to protect from moisture. Avoid direct sunlight
₹3991.00₹7256.25
Inclusive of all taxes
Product Introduction
Palbosure 125mg Capsule contains palbociclib, a cyclin-dependent kinase inhibitor used in anticancer therapy. It is indicated for treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer. The medication works by inhibiting abnormal cell multiplication and is administered in combination with other anticancer drugs.
Common side effects include nausea, vomiting, diarrhoea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any side effects persist or cause concern.
Patients allergic to palbociclib or any ingredient in this capsule should not use this medication. Prior to treatment, inform your doctor of any existing conditions including signs of infection (fever, chills, sore throat), liver disorders, kidney disorders, or intolerance to certain sugars. Report symptoms such as dry cough, chest pain, or difficulty breathing immediately, as these may indicate lung inflammation.
Disclose all current medications, supplements, and herbal medicines to your doctor before starting treatment. Patients must use effective birth control during treatment and for at least three weeks after the final dose. This medication is not recommended for patients under 18 years of age.
Uses
The Palbosure 125mg Capsule is used in the treatment of the following: Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced breast cancer. Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative metastatic breast cancer.
How it works
Palbosure 125mg Capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take Palbosure 125mg Capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Palbosure 125mg Capsules are: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common side effects of Palbosure 125mg Capsules are: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing
Expert Tips
During Palbosure 125mg Capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment as well as for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether Palbosure 125mg Capsule affects your blood cells.
References
- 1. Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf 2. Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf 3. Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/ 4. Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Palbosure 125mg Capsules during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor It is unknown whether Palbosure 125mg Capsules can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is not recommended to take Palbosure 125mg Capsule while breastfeeding as it is not known whether it passes into the breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.